Literature DB >> 2198921

The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.

A J Tapp1, L D Cardozo, E Versi, D Cooper.   

Abstract

Idiopathic detrusor instability is a common cause of incontinence in the elderly for which anticholinergic agents are regularly prescribed. Oxybutynin chloride combines anticholinergic action with direct muscle relaxant properties. We performed a double blind placebo controlled fixed dose cross over study of oxybutynin chloride in post-menopausal women suffering from detrusor instability. We found oxybutynin chloride significantly more effective than placebo at reducing the symptoms of urgency and urge incontinence and more effective at reducing the height of the highest unstable detrusor contraction. This was at the expense of an increased residual urine and considerable side effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2198921     DOI: 10.1111/j.1471-0528.1990.tb02523.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  15 in total

1.  Adverse Events Associated with Nonsurgical Treatments for Urinary Incontinence in Women: a Systematic Review.

Authors:  Ethan M Balk; Gaelen P Adam; Katherine Corsi; Amanda Mogul; Thomas A Trikalinos; Peter C Jeppson
Journal:  J Gen Intern Med       Date:  2019-05-06       Impact factor: 5.128

Review 2.  Improving the tolerability of anticholinergic agents in the treatment of overactive bladder.

Authors:  Roger Dmochowski
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  The placebo effect in overactive bladder syndrome.

Authors:  Altaf Mangera; Christopher R Chapple; Zoe S Kopp; Melanie Plested
Journal:  Nat Rev Urol       Date:  2011-07-05       Impact factor: 14.432

Review 4.  Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Patrick D Meek; Samuel D Evang; Mina Tadrous; Dianne Roux-Lirange; Darren M Triller; Bora Gumustop
Journal:  Dig Dis Sci       Date:  2010-07-02       Impact factor: 3.199

5.  Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers.

Authors:  R H Zobrist; B Schmid; A Feick; D Quan; S W Sanders
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

Review 6.  Comparative tolerability of drug therapies used to treat incontinence and enuresis.

Authors:  R G Owens; M M Karram
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

Review 7.  [Overactive bladder--treatment with antimuscarinic agents].

Authors:  K Höfner
Journal:  Urologe A       Date:  2003-05-20       Impact factor: 0.639

8.  Treatment of detrusor instability with oxybutynin rectal suppositories.

Authors:  H A Winkler; P K Sand
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

9.  Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers.

Authors:  Konstanze Diefenbach; Frank Donath; Agathe Maurer; Sabine Quispe Bravo; Klaus-Dieter Wernecke; Ulrich Schwantes; Jutta Haselmann; Ivar Roots
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 10.  The safety and efficacy of tolterodine extended release in the treatment of overactive bladder in the elderly.

Authors:  Danny Ulahannan; Adrian Wagg
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.